Fractional flow reserve versus angiography-guided strategy in acute myocardial infarction with multivessel disease: a randomized trial
Aims
In patients with acute myocardial infarction (MI) and multivessel coronary artery disease, percutaneous coronary intervention (PCI) of non-infarct-related artery reduces death or MI. However, whether selective PCI guided by fractional flow reserve (FFR) is superior to routine PCI guided by angiography alone is unclear. The current trial sought to compare FFR-guided PCI with angiography-guided PCI for non-infarct-related artery lesions among patients with acute MI and multivessel disease.
Methods and results
Patients with acute MI and multivessel coronary artery disease who had undergone successful PCI of the infarct-related artery were randomly assigned to either FFR-guided PCI (FFR ≤0.80) or angiography-guided PCI (diameter stenosis of >50%) for non-infarct-related artery lesions. The primary end point was a composite of time to death, MI, or repeat revascularization. A total of 562 patients underwent randomization. Among them, 60.0% underwent immediate PCI for non-infarct-related artery lesions and 40.0% were treated by a staged procedure during the same hospitalization. PCI was performed for non-infarct-related artery in 64.1% in the FFR-guided PCI group and 97.1% in the angiography-guided PCI group, and resulted in significantly fewer stent used in the FFR-guided PCI group (2.2 ± 1.1 vs. 2.5 ± 0.9, P < 0.001). At a median follow-up of 3.5 years (interquartile range: 2.7–4.1 years), the primary end point occurred in 18 patients of 284 patients in the FFR-guided PCI group and in 40 of 278 patients in the angiography-guided PCI group (7.4% vs. 19.7%; hazard ratio, 0.43; 95% confidence interval, 0.25–0.75; P = 0.003). The death occurred in five patients (2.1%) in the FFR-guided PCI group and in 16 patients (8.5%) in the angiography-guided PCI group; MI in seven (2.5%) and 21 (8.9%), respectively; and unplanned revascularization in 10 (4.3%) and 16 (9.0%), respectively.
Conclusion
In patients with acute MI and multivessel coronary artery disease, a strategy of selective PCI using FFR-guided decision-making was superior to a strategy of routine PCI based on angiographic diameter stenosis for treatment of non-infarct-related artery lesions regarding the risk of death, MI, or repeat revascularization.
Top-30
Journals
|
1
2
3
4
5
6
7
8
9
|
|
|
Journal of Clinical Medicine
9 publications, 6.98%
|
|
|
European Heart Journal
8 publications, 6.2%
|
|
|
JACC: Cardiovascular Interventions
8 publications, 6.2%
|
|
|
Cardiovascular Revascularization Medicine
6 publications, 4.65%
|
|
|
Circulation: Cardiovascular Interventions
6 publications, 4.65%
|
|
|
Frontiers in Cardiovascular Medicine
5 publications, 3.88%
|
|
|
Clinical Research in Cardiology
5 publications, 3.88%
|
|
|
Journal of the American College of Cardiology
4 publications, 3.1%
|
|
|
Circulation
4 publications, 3.1%
|
|
|
Cardiovascular Intervention and Therapeutics
3 publications, 2.33%
|
|
|
International Journal of Cardiology
3 publications, 2.33%
|
|
|
American Heart Journal
3 publications, 2.33%
|
|
|
American Journal of Cardiology
3 publications, 2.33%
|
|
|
Archives of Cardiovascular Diseases
3 publications, 2.33%
|
|
|
The Lancet
3 publications, 2.33%
|
|
|
New England Journal of Medicine
2 publications, 1.55%
|
|
|
Journal of Cardiovascular Intervention
2 publications, 1.55%
|
|
|
JAMA network open
2 publications, 1.55%
|
|
|
Revista española de cardiología (English ed.)
2 publications, 1.55%
|
|
|
Vessel Plus
2 publications, 1.55%
|
|
|
Revista Espanola de Cardiologia
2 publications, 1.55%
|
|
|
Journal of the Society for Cardiovascular Angiography & Interventions
2 publications, 1.55%
|
|
|
Journal of Interventional Cardiology
2 publications, 1.55%
|
|
|
Reviews in Cardiovascular Medicine
2 publications, 1.55%
|
|
|
Cardiovascular Drugs and Therapy
2 publications, 1.55%
|
|
|
Minerva Cardiology and Angiology
2 publications, 1.55%
|
|
|
BMC Cardiovascular Disorders
2 publications, 1.55%
|
|
|
Archives des Maladies du Coeur et des Vaisseaux - Pratique
1 publication, 0.78%
|
|
|
JAMA Cardiology
1 publication, 0.78%
|
|
|
1
2
3
4
5
6
7
8
9
|
Publishers
|
5
10
15
20
25
30
35
40
45
|
|
|
Elsevier
45 publications, 34.88%
|
|
|
Springer Nature
16 publications, 12.4%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
14 publications, 10.85%
|
|
|
Oxford University Press
10 publications, 7.75%
|
|
|
MDPI
10 publications, 7.75%
|
|
|
Frontiers Media S.A.
5 publications, 3.88%
|
|
|
American Medical Association (AMA)
4 publications, 3.1%
|
|
|
Massachusetts Medical Society
3 publications, 2.33%
|
|
|
Wiley
3 publications, 2.33%
|
|
|
XMLink
2 publications, 1.55%
|
|
|
OAE Publishing Inc.
2 publications, 1.55%
|
|
|
IMR Press
2 publications, 1.55%
|
|
|
Edizioni Minerva Medica
2 publications, 1.55%
|
|
|
SAGE
1 publication, 0.78%
|
|
|
BMJ
1 publication, 0.78%
|
|
|
Research Square Platform LLC
1 publication, 0.78%
|
|
|
Taylor & Francis
1 publication, 0.78%
|
|
|
Korean Society of Circulation
1 publication, 0.78%
|
|
|
Media Sphere Publishing House
1 publication, 0.78%
|
|
|
Silicea - Poligraf, LLC
1 publication, 0.78%
|
|
|
Paediatrician Publishers LLC
1 publication, 0.78%
|
|
|
Nippon-Shinzobyo-Gakkai/Japanese College of Cardiology
1 publication, 0.78%
|
|
|
5
10
15
20
25
30
35
40
45
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.